4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Image_display > asuragen/AmplideX® PCR/CE FMR1 Reagents/100/76008
商品详细asuragen/AmplideX® PCR/CE FMR1 Reagents/100/76008
asuragen/AmplideX® PCR/CE FMR1 Reagents/100/76008
asuragen/AmplideX® PCR/CE FMR1 Reagents/100/76008
商品编号: 76008
品牌: asuragen
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 影像显示
公司分类: Image_display
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

AmplideX® PCR/CE FMR1 Reagents

AmplideX FMR1AmplideX PCR/CE FMR1 Reagents* are market-leading research tools for the detection of CGG repeats in the fragile X mental retardation (FMR1) gene. These reagents provide a PCR-only approach based on Triplet Repeat Primed PCR (TP-PCR) design to reliably amplify and detect all alleles including Full Mutations.

Features & Benefits

AmplideX PCR/CE FMR1 Reagents* have created an easy-to-use, accessible, high performance method for laboratories to reliably analyze CGG repeats and detect interrupting AGG sequences in the FMR1 gene.

Reduced ComplexityEase-of-analysis of the FMR1 gene has been simplified through:

  • Implementation of proprietary PCR solution for amplifying GC-rich regions
  • Automation of result calling using AmplideX PCR/CE FMR1 Reporter* 

Optimized WorkflowValuable operator hands-on time has been significantly reduced through:

  • Direct injection of PCR products (no PCR clean up) in to Capillary Electrophoresis platforms
  • Decreased need for Southern blot analysis (up to 50 fold)
  • End-to-end solution for FMR1 analysis including all necessary reagents and software

Quality PerformancePerforming FMR1 Analysis with Greater Sensitivity and Accuracy:

  • Detection of all allele expansions, including low abundance full mutation size mosaics with up to at least 1300 CGG repeats
  • Up to 875 fold more sensitive than Southern blot1
  • Resolution of female homozygous and heterozygous samples and indication of interrupting AGG sequences
  • Proven performance as indicated by more than 30 peer reviewed publications

*For Research Use Only. Not for use in diagnostic procedures.

Download Brochure

Product Description

Analytical Characteristics of AmplideX PCR/CE FMR1 Reagents*:

  • Detects all alleles including low abundance full mutations (Figure 1)
  • Accurately sizes any repeat up to 200 CGG repeats (Figure 2)
  • Resolves female zygosity (Figure 3)
  • Detects presence of AGG interruptions (Figure 4)

Figure 1: Amplification of Asuragen’s Methylation and Sensitivity Control which has a 5% full mutation in a background of 95% Normal

AmplideX Methylation and Sensitivity Control

Figure 2. Female premutation sample with accurate sizing of Normal (30 CGG) and Pre mutation allele (56 CGG)

AmplideX Female premutation sample

Figure 3: The difference in the “stutter” peak patterns of homozygous and heterozygous female provides a clear resolution of zygosity

AmplideX resolves female zygosity

Figure 4. Female Full Mutation sample with AGG interruptions as indicated by sudden decrease in peak heights of the “stutter” peak profile

AmplideX Female Full Mutation sample

Ordering

Product NameNumber of ReactionsCatalog Number
AmplideX PCR/CE FMR1 Control24 UL49513
AmplideX mPCR FMR1 Control24 UL49514
AmplideX PCR/CE FMR1 Reagents10049402
AmplideX mPCR FMR1 Kit2449442
AmplideX PCR/CE FMR1 ReporterN/A49576

T 1-877-777-1874; 512-681-5200 F 512-681-5202 E orders@asuragen.com

View Sales Contacts

References

  1. Referenced in over 30 peer reviewed publications and used in over 200 laboratories, the AmplideX® PCR/CE FMR1 Reagents* are globally recognized as best-in-class for assessment of CGG repeats in the FMR1 gene.
    • Key resources
    • Videos

AmplideX® PCR/CE FMR1 Kit

AmplideX FMR1AmplideX PCR/CE FMR1 Kit is an in vitro diagnostic (IVD) device for use in clinical laboratories for detection of the CGG repeats in the fragile X mental retardation (FMR1) gene. The device is intended to aid in the diagnosis of fragile X syndrome and fragile X associated disorders, e.g. tremor and ataxia syndrome (FX-TAS) and primary ovarian insufficiency (FXPOI), through determination of CGG repeat length up to 200 CGG and detection of alleles greater than 200 CGG. The kit provides a PCR-only approach based on Triplet Repeat Primed PCR (TP-PCR) design to reliably amplify and detect all alleles including Full Mutations.

Features & Benefits

AmplideX PCR/CE FMR1 Kit has created an easy-to-use, accessible, high performance method for laboratories to reliably analyze CGG repeats and detect interrupting AGG sequences in the FMR1 gene.

Reduced ComplexityEase-of-analysis of the FMR1 gene has been simplified through:

  • Implementation of proprietary PCR solution for amplifying GC-rich regions
  • Automation of result calling using AmplideX PCR/CE FMR1 Reporter 

Optimized WorkflowValuable operator hands-on time has been significantly reduced through:

  • Direct injection of PCR products (no PCR clean up) in to Capillary Electrophoresis platforms
  • Decreased need for Southern blot analysis (up to 50 fold)
  • End-to-end solution for FMR1 analysis including all necessary reagents and software

Quality PerformancePerforming FMR1 Analysis with Greater Sensitivity and Accuracy:

  • Detection of all allele expansions, including low abundance full mutation size mosaics with up to at least 1300 CGG repeats
  • Up to 875 fold more sensitive than Southern blot1
  • Resolution of female homozygous and heterozygous samples and indication of interrupting AGG sequences
  • Proven performance as indicated by more than 30 peer reviewed publications

Product Description

Analytical Characteristics of AmplideX PCR/CE FMR1 Kit:

  • Proven clinical accuracy compared to Southern Blot (Table 1)
  • Detects all alleles including low abundance full mutations (Figure 1)
  • Accurately sizes all alleles up to 200 CGG repeats (Figure 2)
  • Resolves female zygosity (Figure 3)
  • Detects presence of AGG interruptions (Figure 4)

Table 1: Diagnostic Sensitivity of 100%; Diagnostic Specificity of 98.4% and Overall Accuracy of 99%AmplideX has proven clinical accuracy compared to Southern Blot*These 2 samples presented premutation alleles by both methods and low intensity full mutation alleles detected only by the AmplideX PCR/CE FMR1 Kit

Figure 1: Amplification of Asuragen’s Methylation and Sensitivity Control which has a 5% full mutation in a background of 95% Normal

AmplideX Methylation and Sensitivity Control

Figure 2. Female Pre-mutation sample with accurate sizing of Normal (30 CGG) and Pre-mutation allele (56 CGG)

AmplideX Female premutation sample

Figure 3: The difference in the “stutter” peak patterns of homozygous and heterozygous female provides a clear resolution of zygosity

AmplideX resolves female zygosity

Figure 4. Female Full Mutation sample with AGG interruptions as indicated by sudden decrease in peak heights of the “stutter” peak profile

AmplideX Female Full Mutation sample

Ordering

Product NameNumber of ReactionsCatalog Number
AmplideX PCR/CE FMR1 Control*24 UL49513
AmplideX mPCR FMR1 Control*24 UL49514
AmplideX PCR/CE FMR1 Reagents*10049402
AmplideX PCR/CE FMR1 Kit10076008
AmplideX mPCR FMR1 Kit*2449442
AmplideX PCR/CE FMR1 Reporter*N/A49576

T 1-877-777-1874; 512-681-5200 F 1-512-681-5202 E orders@asuragen.com

View Sales Contacts

References

  1. Referenced in over 30 peer reviewed publications and used in over 200 laboratories, the AmplideX® PCR/CE FMR1 Reagents* are globally recognized as best-in-class for assessment of CGG repeats in the FMR1 gene.
    • Key resources
    • Videos
品牌介绍
asuragen的QuantideX®qPCR BCR-ABL次要试剂盒(RUO)BCR-ABL血液癌细胞该QuantideX ® qPCR的BCR-ABL轻微套件(RUO)是临床研究工具,使超灵敏和精确的检测BCR-ABL1从全血标本轻微融合基因(e1a2)。在简单的工作流程和最佳的一流的灵敏度与确立的全面建设FDA批准QuantideX ® qPCR的BCR-ABL IS套装,小工具允许实验室和临床研究人员研究疾病的生物学这一非常罕见的,但不同白血病变异与前所未有的轻松。特点与优势分析特性订购方式特点与优势QuantideX qPCR BCR-ABL次要试剂盒(RUO)通过无与伦比的灵敏度和优化的实验室效率提供了高性能。降低复杂性易于数据分析和报告:充分利用了QuantideX ® qPCR的BCR-ABL IS套装的工作流程概念简化实施随附的软件可自动计算BCR-ABL1 / ABL1%比率,无需手动计算优化的工作流程通过以下方式大大减少了宝贵的操作员动手时间:多重设计可在同一反应中扩增并检测融合基因和对照基因单一供应商共同采购和控制质量的全包试剂预混试剂可减少预混液的移液步骤通过高灵敏度的检测方法可靠,可靠地检测 BCR-ABL1次要转录本的质量表现:超灵敏的检测下限(LOD):对数减少4.61(比率为0.0025%)在不影响分析特异性的情况下提高分析灵敏度:结合了空白限度(LOB)以防止误判非白血病低阳性基于铠装RNA®的标准品可提供真正的RNA定量